Supreme Court Rules Prescriber Intent Matters under the Controlled Substances Act

By Sarah Wirskye - On

In Xiulu Ruan V. United States, No. 20–1410 (June 27, 2022), the Supreme Court ruled that under the Controlled Substances Act for prescribing of opioids and other addictive drugs, the government must show that doctors knew they lacked a legitimate medical purpose. In this case petitioner doctors Xiulu Ruan and Shakeel Kahn successfully appealed …

Fifth Circuit Requires Law Firm to Produce Client Names in Response to IRS Summons

By Sarah Wirskye - On

In Taylor Lohmeyer Law Firm P.L.L.C. v. United States, 957 F.3d 505 (2020), the Fifth Circuit affirmed the district court’s ruling that a law firm’s clients’ names were not protected by the attorney client privilege. Taylor Lohmeyer, a Texas law firm, filed an action to quash an IRS John Doe summons. The IRS had …

Department of Justice Announces Coordinated Law Enforcement Action to Combat Healthcare-Related Covid Fraud

By Sarah Wirskye - On

The Department of Justice (DOJ) announced a nationwide coordinated law enforcement action to combat healthcare-related covid fraud. On April 21, 2022, the DOJ announced criminal charges against 21 defendants in nine federal districts across the United States for their alleged participation in various health care related fraud schemes that exploited the COVID-19 pandemic. These …

Defense Victories Regarding the Knowledge Requirement under the False Claims Act

By Sarah Wirskye - On

The False Claims Act (31 U.S.C. §§3729-3733; “FCA”) imposes liability on persons and companies who defraud the government. Last year, DOJ recovered more than $5.6 billion in settlements and judgments from civil cases involving fraud and false claims against the government. Notably, of the over $5.6 billion recovered, over $5 billion involved the health …

Department of Health and Human Services’ (HHS) Office of Inspector General (OIG) releases Solutions to Reduce Fraud, Waste and Abuse in HHS Programs

By Sarah Wirskye - On

The U.S. Department of Health and Human Services’ (HHS) Office of Inspector General (OIG) released its annual Solutions to Reduce Fraud, Waste, and Abuse in HHS Programs: OIG’s Top Unimplemented Recommendations. The OIG directed most of its recommendations to CMS to help “reduce improper payments, prevent and deter fraud, and foster economical payment policies.” Specific …

Department of Justice Publishes FY 2021 False Claims Act Data

By Sarah Wirskye - On

The Department of Justice (DOJ) published fiscal year 2021 False Claims Act data. The False Claims Act (31 U.S.C. §§3729-3733) (“FCA”) imposes liability on persons and companies who defraud the government.  It is the federal government’s primary tool in combating fraud against the Government. https://wirskyelawfirm.com/false-claims-act-basics/.  The DOJ recovered more than $5.6 billion in settlements …

What to Expect in Healthcare Fraud Prosecutions in 2022

By Sarah Wirskye - On

The government’s focus on healthcare fraud and abuse continued in 2021.  Even stronger enforcement is expected by Biden’s new Secretary of Health and Human Services Xavier Becerra, who previously served as California’s Attorney General. The following trends seen in 2021 are expected to continue in 2022. Kickbacks and Referral Arrangements. The government’s focus on …

Biden Administration Unveils United States’ Strategy on Countering Corruption

By Sarah Wirskye - On

In December 2021, the Biden administration released the United States Strategy on Countering Corruption (“Strategy”). Htttps://www.whitehouse.gov/wp-content/uploads/2021/12/United-States-Strategy-on-Countering-Corruption.pdf. The Strategy follows up on establishing the fight against corruption as a core national security interest of the United States in the National Security Study Memorandum-1 (NSSM-1) earlier in 2021. The Strategy discusses the impacts of corruption and …

DOJ Announces New White Collar Criminal Enforcement Policies

By Sarah Wirskye - On

Deputy Attorney General (DAG) Lisa Monaco announced the Department of Justice’s (DOJ’s) new approach to prosecuting corporate crime at the ABA’s 36th National Institute on White Collar Crime. Htttps://www.justice.gov/opa/speech/deputy-attorney-general-lisa-o-monaco-gives-keynote-address-abas-36th-national-institute. The primary announcements addressed: (1) individual accountability, (2) company prior conduct, and (3) corporate monitors. Individual Accountability The DOJ is restoring prior guidance that to …

District of Maryland Dismisses False Claims Act Action based on Conclusory Intent Allegations

By Sarah Wirskye - On

In United States ex rel. Fitzer v. Allergan, Inc., et al., 1:17-cv-00668-SAG (D. Md. Sept. 10, 2021), the court dismissed a declined False Claims Act (FCA) action, under 31 U.S.C. § 3729, et seq. The court dismissed the action without prejudice, based upon a holding that the allegations that defendants knew they were acting …